(Q80714802)
Statements
Depot haloperidol treatment in outpatients with schizophrenia on monotherapy: impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcome (English)
Georgios Panagiotidis
Holger W Arthur
Marja-Liisa Dahl
Folke Sjöqvist